Help Shape the Future of Myasthenia Gravis Treatment
Myasthenia Gravis
If you’re living with myasthenia gravis MG and looking for new treatment options, our clinical trial could offer hope for better symptom management.
Are You Eligible?
Check Your Eligibility Now
You may be eligible for our myasthenia gravis clinical trials if you:
Additional eligibility criteria may apply. Our research team will discuss full eligibility requirements with you during your initial consultation.
Are male or female, 18 years or older
Have confirmed myasthenia gravis diagnosis
Are on stable standard-of-care treatment
Meet specific inclusion criteria for the study
myasthenia gravis clinical trials
Current Trials
- Recruiting Now​
Myasthenia gravis Clinical Trial
Myasthenia gravis (gMB) is a rare chronic condition that causes weakness if voluntary muscles including
- Age: 18-75 years old
Myasthenia gravis is a rare autoimmune disease affecting approximately 33.7 per 100,000 people in the UK. This condition happens when your immune system attacks the connection points between your nerves and muscles called acetylcholine receptors. Many patients with myasthenia gravis experience fluctuating muscle weakness and fatigue that significantly impacts daily life
clinical trials myasthenia gravis
Understanding Myasthenia Gravis and Treatment Advances
Myasthenia gravis is a rare autoimmune disease that affects the muscles you control, like those in your face, arms, and legs. This condition happens when your immune system attacks the wrong targets – the connection points between your nerves and muscles called acetylcholine receptors. This attack causes muscle weakness and tiredness, which makes this condition so difficult to live with.
Myasthenia gravis MG affects people in different ways, but the basic problem is the same: your immune system makes antibodies that get in the way of acetylcholine receptors – the spots where your nerves connect to your muscles. This leads to the typical weakness and tiredness you experience.
How this autoimmune disease usually affects people:
- Muscle weakness that gets worse when you're active but gets better when you rest
- Drooping eyelids and seeing double
- Trouble with facial expressions, chewing, and swallowing
- Weakness in your neck, arms, and legs
- Problems with speech and breathing in more serious cases
- Symptoms that change from day to day and can sometimes become life-threatening
myasthenia gravis clinical trials
How does it work?
Register Your Interest
Contact our research team by phone on 03300 575 838 or complete our confidential interest form online. We’ll explain the myasthenia gravis clinical trial and answer your questions with no pressure or obligation. This initial conversation is completely private and helps us determine if the study might be suitable for you.
Attend Your Screening Visit
We’ll arrange a screening visit at our Ilford or Swinton research centre where our qualified medical professionals will review your myasthenia gravis MG diagnosis and treatment history. This assessment includes evaluating your current symptoms, medication stability, and inclusion criteria to ensure the double blind placebo controlled study is safe and appropriate for you.
Begin Your Trial Participation
Once enrolled, you’ll start your first visit at our research facility with a clear schedule of all appointments. Throughout the clinical trial, you’ll receive regular monitoring and support from our dedicated team, who understand this autoimmune disease, with your safety and well-being as our top priority.
clinical trials myasthenia gravis
How You Can Benefit from Participating
Taking part in our myasthenia gravis clinical research trials offers several potential benefits:
Access to Emerging Myasthenia Gravis Treatments
- Early access to new medications specifically designed for treating myasthenia gravis
- Opportunity to try treatments not yet available through standard NHS care for this autoimmune disease
- Potential benefit from medicines targeting acetylcholine receptors and immune system dysfunction
- Access to innovative approaches being tested in double blind placebo controlled clinical trials
Specialist Neuromuscular Care & Monitoring
- Regular assessments by qualified medical professionals specialising in myasthenia gravis MG
- Comprehensive monitoring using validated scales like MG ADL (Myasthenia Gravis Activities of Daily Living)
- Close tracking of muscle weakness patterns and symptom changes throughout the study
- Rigorous efficacy and safety monitoring to ensure your wellbeing with this autoimmune disease
Contributing to Rare Disease Research
- Help advance treatment options for the thousands living with patients with generalised myasthenia gravis
- Support research into this rare autoimmune disease that receives limited funding and attention
- Contribute valuable data that could lead to approved treatments for future myasthenia gravis MG patients
- Participate in clinical trials myasthenia gravis research exploring new approaches like CAR T cell therapy
clinical trials myasthenia gravis
Why Choose 4MCS?
You may be eligible for our myasthenia gravis clinical trials if you:
Established Expertise:
4MCS specialises in clinical research with over 130 years of combined experience in medical research across different areas.
Proven Track Record:
Our team has successfully run studies from early to late phases, contributing to important medical advances.
Patient-Centred Care:
We’ve worked with over 35,000 people in our research database, ensuring individual attention throughout your experience.
Comprehensive Support:
From first contact to study completion, our team provides ongoing support to ensure you feel informed and comfortable.
Enquire to participate
Become A Participant
clinical trials myasthenia gravis
Frequently Asked Questions
We understand you may have questions about participating in our myasthenia gravis clinical trial. Here are answers to some of the most common questions we receive from potential participants.
Am I eligible for the clinical trial?
To participate in our clinical trials for myasthenia gravis (MG) research, you need to be at least 18 years old with a confirmed myasthenia gravis MG diagnosis. Key inclusion criteria include having a stable current treatment and meeting specific medical requirements for safe participation.
Our research team will review your medical history, including whether you have positive myasthenia gravis with acetylcholine receptor antibodies or MuSK MG (muscle-specific kinase type). We’ll assess your current symptoms and treatments to determine if this clinical trial is appropriate for your situation.
What does stable treatment mean?
Stable standard-of-care treatment means your current myasthenia gravis medications haven’t needed significant changes recently. This might include acetylcholinesterase inhibitors, immunosuppressants, or corticosteroids that help manage your autoimmune disease.
Stability is crucial for clinical trial safety and scientific validity. When we test new treatments in double blind, controlled studies, we need a consistent baseline treatment to accurately measure the efficacy and safety of the study medication.
What does the clinical trial involve?
Our myasthenia gravis clinical trials involve regular visits where you’ll receive comprehensive assessments from our specialised team. You’ll receive either the new medication or a placebo – neither you nor researchers will know which during the double blind study period.
We’ll monitor your progress using standardised measures like MG ADL scores to track improvements in daily activities. Regular safety monitoring includes checking for side effects and ensuring the treatment doesn’t cause any life-threatening complications.
Are new treatments showing promise?
Recent advances in treating myasthenia gravis are encouraging. New approaches targeting different aspects of this autoimmune disease include FcRn inhibitors, complement inhibitors, and emerging therapies like CAR T cell therapy (chimeric antigen receptor T cells).
Some clinical trials in myasthenia gravis research have already led to new approved treatments, while other studies explore open-label trials of innovative approaches. The field has seen remarkable progress in understanding how to better target the immune system problems causing muscle weakness.
What about innovative treatments like CAR T therapy?
Cutting-edge approaches like CAR T cell therapy (chimeric antigen receptor T cell treatment) represent exciting developments for patients with generalised myasthenia gravis. These treatments modify your immune system cells to better fight the autoimmune disease.
While our current clinical trial focuses on established approaches with proven efficacy and safety profiles, the broader field includes research into these advanced treatments for treating myasthenia gravis more effectively.